全文获取类型
收费全文 | 1142篇 |
免费 | 101篇 |
出版年
2023年 | 20篇 |
2022年 | 29篇 |
2021年 | 49篇 |
2020年 | 25篇 |
2019年 | 36篇 |
2018年 | 40篇 |
2017年 | 37篇 |
2016年 | 42篇 |
2015年 | 92篇 |
2014年 | 87篇 |
2013年 | 113篇 |
2012年 | 108篇 |
2011年 | 93篇 |
2010年 | 57篇 |
2009年 | 52篇 |
2008年 | 51篇 |
2007年 | 33篇 |
2006年 | 33篇 |
2005年 | 30篇 |
2004年 | 20篇 |
2003年 | 17篇 |
2002年 | 25篇 |
2001年 | 21篇 |
2000年 | 7篇 |
1999年 | 8篇 |
1998年 | 3篇 |
1997年 | 8篇 |
1996年 | 3篇 |
1995年 | 4篇 |
1993年 | 4篇 |
1992年 | 7篇 |
1991年 | 4篇 |
1990年 | 7篇 |
1989年 | 4篇 |
1988年 | 4篇 |
1987年 | 10篇 |
1986年 | 4篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1972年 | 3篇 |
1970年 | 4篇 |
1969年 | 2篇 |
1967年 | 3篇 |
排序方式: 共有1243条查询结果,搜索用时 687 毫秒
971.
William Christopher Long Katherine M. Swiney Caitlin Harris Heather N. Page Robert J. Foy 《PloS one》2013,8(4)
Ocean acidification, a decrease in the pH in marine waters associated with rising atmospheric CO2 levels, is a serious threat to marine ecosystems. In this paper, we determine the effects of long-term exposure to near-future levels of ocean acidification on the growth, condition, calcification, and survival of juvenile red king crabs, Paralithodes camtschaticus, and Tanner crabs, Chionoecetes bairdi. Juveniles were reared in individual containers for nearly 200 days in flowing control (pH 8.0), pH 7.8, and pH 7.5 seawater at ambient temperatures (range 4.4–11.9 °C). In both species, survival decreased with pH, with 100% mortality of red king crabs occurring after 95 days in pH 7.5 water. Though the morphology of neither species was affected by acidification, both species grew slower in acidified water. At the end of the experiment, calcium concentration was measured in each crab and the dry mass and condition index of each crab were determined. Ocean acidification did not affect the calcium content of red king crab but did decrease the condition index, while it had the opposite effect on Tanner crabs, decreasing calcium content but leaving the condition index unchanged. This suggests that red king crab may be able to maintain calcification rates, but at a high energetic cost. The decrease in survival and growth of each species is likely to have a serious negative effect on their populations in the absence of evolutionary adaptation or acclimatization over the coming decades. 相似文献
972.
973.
Erica H. Layer Sarah W. Beckham Lilian Mgeni Catherine Shembilu Romani B. Momburi Caitlin E. Kennedy 《PloS one》2013,8(8)
While male circumcision reduces the risk of female-to-male HIV transmission and certain sexually transmitted infections (STIs), there is little evidence that circumcision provides women with direct protection against HIV. This study used qualitative methods to assess women’s perceptions of male circumcision in Iringa, Tanzania. Women in this study had strong preferences for circumcised men because of the low risk perception of HIV with circumcised men, social norms favoring circumcised men, and perceived increased sexual desirability of circumcised men. The health benefits of male circumcision were generally overstated; many respondents falsely believed that women are also directly protected against HIV and that the risk of all STIs is greatly reduced or eliminated in circumcised men. Efforts to engage women about the risks and limitations of male circumcision, in addition to the benefits, should be expanded so that women can accurately assess their risk of HIV or STIs during sexual intercourse with circumcised men. 相似文献
974.
975.
976.
Childhood diarrhea is a significant problem in many developing countries and E. coli is a main causative agent of diarrhea in young children. Lysozyme is an antimicrobial protein highly expressed in human milk, but not ruminant milk, and is thought to help protect breastfeeding children against diarrheal diseases. We hypothesized that consumption of milk from transgenic goats which produce human lysozyme (hLZ-milk) in their milk would accelerate recovery from bacterial-induced diarrhea. Young pigs were used as a model for children and infected with enterotoxigenic E. coli. Once clinical signs of diarrhea developed, pigs were fed hLZ-milk or non-transgenic control goat milk three times a day for two days. Clinical observations and complete blood counts (CBC) were performed. Animals were euthanized and samples collected to assess differences in histology, cytokine expression and bacterial translocation into the mesenteric lymph node. Pigs consuming hLZ-milk recovered from clinical signs of infection faster than pigs consuming control milk, with significantly improved fecal consistency (p = 0.0190) and activity level (p = 0.0350). The CBC analysis showed circulating monocytes (p = 0.0413), neutrophils (p = 0.0219), and lymphocytes (p = 0.0222) returned faster to pre-infection proportions in hLZ-milk fed pigs, while control-fed pigs had significantly higher hematocrit (p = 0.027), indicating continuing dehydration. In the ileum, pigs fed hLZ-milk had significantly lower expression of pro-inflammatory cytokine IL-8 (p = 0.0271), longer intestinal villi (p<0.0001), deeper crypts (p = 0.0053), and a thinner lamina propria (p = 0.0004). These data demonstrate that consumption of hLZ-milk helped pigs recover from infection faster, making hLZ-milk an effective treatment of E. coli-induced diarrhea. 相似文献
977.
Mark A. Marzinke Caitlin H. Choi Li Chen Ie-Ming Shih Daniel W. Chan Hui Zhang 《Molecular & cellular proteomics : MCP》2013,12(2):356-368
While ovarian cancer remains the most lethal gynecological malignancy in the United States, there are no biomarkers available that are able to predict therapeutic responses to ovarian malignancies. One major hurdle in the identification of useful biomarkers has been the ability to obtain enough ovarian cancer cells from primary tissues diagnosed in the early stages of serous carcinomas, the most deadly subtype of ovarian tumor. In order to detect ovarian cancer in a state of hyperproliferation, we analyzed the implications of molecular signaling cascades in the ovarian cancer cell line OVCAR3 in a temporal manner, using a mass-spectrometry-based proteomics approach. OVCAR3 cells were treated with EGF1, and the time course of cell progression was monitored based on Akt phosphorylation and growth dynamics. EGF-stimulated Akt phosphorylation was detected at 12 h post-treatment, but an effect on proliferation was not observed until 48 h post-exposure. Growth-stimulated cellular lysates were analyzed for protein profiles between treatment groups and across time points using iTRAQ labeling and mass spectrometry. The protein response to EGF treatment was identified via iTRAQ analysis in EGF-stimulated lysates relative to vehicle-treated specimens across the treatment time course. Validation studies were performed on one of the differentially regulated proteins, lysosomal-associated membrane protein 1 (LAMP-1), in human tissue lysates and ovarian tumor tissue sections. Further, tissue microarray analysis was performed to demarcate LAMP-1 expression across different stages of epithelial ovarian cancers. These data support the use of this approach for the efficient identification of tissue-based markers in tumor development related to specific signaling pathways. LAMP-1 is a promising biomarker for studies of the progression of EGF-stimulated ovarian cancers and might be useful in predicting treatment responses involving tyrosine kinase inhibitors or EGF receptor monoclonal antibodies.Ovarian cancer is the leading cause of death from gynecologic malignancy in the United States, and the fifth leading cause of cancer-related deaths in women (1). Epithelial ovarian cancers are extensively heterogeneous; histological sub-classification by cell type includes serous, endometrioid, clear-cell, mucinous, transitional, squamous, and undifferentiated (2). Serous epithelial cancers are the most commonly diagnosed epithelial ovarian cancer subtype and are associated with the majority of ovarian-cancer-related deaths (1).From a molecular perspective, the basic characteristic of any cancerous cell is its ability to grow uncontrollably. As a cell proliferates, a cascade of molecular and morphological changes occurs, including the activation of signaling cascades that modulate cytoskeletal dynamics, cell cycle progression, and angiogenesis (3–5). In addition to the unrestrained aberrant proliferation of cancer cells, other processes are required for disease progression, including changes in cellular adhesion to endothelial cells and in the extracellular microenvironment (6). It is important to note, however, that cancer cell progression is not an instantaneous event, and the demarcation between non-cancer and cancer is not static. It is postulated that epithelial cancer cells transition to a highly motile and invasive mesenchymal cell type, and this epithelial-to-mesenchymal transition is a critical molecular mechanism in tumor progression and metastasis (6). Several important signaling cascades have been implicated in this transition, including those mediated by EGF, PDGF, and TGFβ and those involving PI3K/Akt activation (7, 8). Thus, biomarkers of cancer progression can serve as indicators of disease etiology and potential staging, as well as predictive markers of therapeutic regimen responses. The identification of differentially expressed proteins during cancer metastasis has the potential to be utilized both prognostically with regard to metastatic development and predictively, through the implementation of pathway-specific therapies.Molecular analyses indicate the oncogenic role of the epidermal growth factor receptor (EGFR) in several human cancers, including lung cancers and Her2-amplified breast cancers (9). However, less is known regarding the implications of aberrant EGFR expression in ovarian cancer progression, particularly in terms of increased activation of downstream signaling cascades and efficacious therapeutic regimens. Studies illustrate overamplification of the EGFR gene in between 4% and 22% of ovarian cancers, with aberrant protein expression in up to 60% of ovarian malignancies (10–12). Aberrant EGFR expression has been associated with high tumor grade, increased cancerous cell proliferation, and poorer patient outcomes (12–15). Gene amplification and the overexpression of other EGFR family members such as Her2 and ErbB3 have also been reported in epithelial ovarian cancers (15). Further, studies performed in vitro illustrate the ability of EGF to induce DNA synthesis and stimulate cell growth in OVCAR3 cells (16).Although EGFR and downstream EGF-regulated signaling cascades have been implicated in ovarian malignancies, the treatment of ovarian tumors with anti-EGFR agents has induced minimal response. Targeted EGFR therapies fall into two categories: monoclonal antibodies that target the receptor extracellular domain to prevent ligand binding, and tyrosine kinase inhibitors (TKIs), which aim to prevent the activation of downstream signaling cascades. Although EGFR inhibitors exhibit modest success in vitro, no agents have been approved by the U.S. Food and Drug Administration for the treatment of malignant ovarian tumors (17). Among other therapeutic approaches, studies have looked at the potential efficacy of the TKIs erlotinib and gefitinib in the treatment of ovarian cancers; unfortunately, neither drug was effective in eliciting a significant response in ovarian tumor treatment (12, 15, 18, 19). However, the identification of markers of pathway-stimulated processes might help to stratify disease and select patients with EGF signaling activation. The identified markers might facilitate the prediction of treatment responses.MS-based proteomic studies have been heavily implemented in the identification of candidate biomarkers in a variety of specimen sources ranging from epithelial ovarian cancer tissue to immortalized cell lines and cultured media (20–22). The human adenocarcinoma OVCAR3 cell line is derived from an epithelial ovarian cancer with a high grade serous cell type and exhibits many of the molecular and morphological aspects of serous epithelial cancers (23, 24). This cell line can be stimulated to promote or inhibit cellular proliferation using various molecular agonists and antagonists (23–25). Because of the molecular and morphological similarities between the OVCAR3 cell line and ovarian adenocarcinoma cells, it serves as an appropriate high-throughput surrogate for candidate biomarker identification. Further, the analysis of a single cell line allows for the identification of temporal protein regulation within a single homogeneous cell population using an orthogonal approach.In the present study, the OVCAR3 cell line was treated with the hyperproliferative molecule EGF or the PI3K/Akt inhibitor over a 48-h time course. Three time points were analyzed for biochemical and molecular changes, including Akt phosphorylation status and increased proliferation. Additionally, growth-stimulated and growth-inhibited cellular lysates were analyzed using quantitative proteomics with iTRAQ and MS/MS, and these analyses illustrated comparable global protein profiles between treatment groups and across time points. Differentially expressed proteins were identified in growth-stimulated cells as opposed to control (vehicle-treated) cells. One of the differentially regulated proteins, lysosomal-associated membrane protein 1 (LAMP-1, also known as CD107a), was further verified via immunoblotting and immunohistochemical analyses in normal and ovarian cancer tissues, in addition to tissue microarray analysis. This study demonstrates that through the use of a growth-stimulated cell culture model using EGF, the rapid identification of differentially regulated proteins as proliferation progresses may be achieved via large-scale proteomic analyses. The identification of regulated proteins along the pathway of increased cellular growth and proliferation might serve a predictive role in treatment outcomes. LY294002相似文献
978.
Hicks CW Li Y Okugawa S Solomon SB Moayeri M Leppla SH Mohanty A Subramanian GM Mignone TS Fitz Y Cui X Eichacker PQ 《American journal of physiology. Heart and circulatory physiology》2011,300(3):H1108-H1118
While anthrax edema toxin produces pronounced tachycardia and lethal toxin depresses left ventricular (LV) ejection fraction in in vivo models, whether these changes reflect direct cardiac effects as opposed to indirect ones related to preload or afterload alterations is unclear. In the present study, the effects of edema toxin and lethal toxin were investigated in a constant pressure isolated perfused rat heart model. Compared with control hearts, edema toxin at doses comparable to or less than a dose that produced an 80% lethality rate (LD(80)) in vivo in rats (200, 100, and 50 ng/ml) produced rapid increases in heart rate (HR), coronary flow (CF), LV developed pressure (LVDP), dP/dt(max), and rate-pressure product (RPP) that were most pronounced and persisted with the lowest dose (P ≤ 0.003). Edema toxin (50 ng/ml) increased effluent and myocardial cAMP levels (P ≤ 0.002). Compared with dobutamine, edema toxin produced similar myocardial changes, but these occurred more slowly and persisted longer. Increases in HR, CF, and cAMP with edema toxin were inhibited by a monoclonal antibody blocking toxin uptake and by adefovir, which inhibits the toxin's intracellular adenyl cyclase activity (P ≤ 0.05). Lethal toxin at an LD(80) dose (50 ng/ml) had no significant effect on heart function but a much higher dose (500 ng/ml) reduced all parameters (P ≤ 0.05). In conclusion, edema toxin produced cAMP-mediated myocardial chronotropic, inotropic, and vasodilatory effects. Vasodilation systemically with edema toxin could contribute to shock during anthrax while masking potential inotropic effects. Although lethal toxin produced myocardial depression, this only occurred at high doses, and its relevance to in vivo findings is unclear. 相似文献
979.
Anne Christine Steenkjær Hastrup Caitlin HowellBo Jensen Frederick Green III 《International biodeterioration & biodegradation》2011,65(3):553-559
Small, low molecular weight, non-enzymatic compounds have been linked to the early stages of brown rot decay as the enzymes involved with holocellulose degradation are too large to penetrate the S3 layer of intact wood cells. We investigated the most notable of these compounds, i.e. hydrogen peroxide, iron, and oxalic acid. The former two are involved in the Fenton reaction in which they react to form hydroxyl radicals, which cause an accelerated depolymerization in cotton cellulose. We found the same reaction to be caused by both iron Fe3+ and Fe2+. A 10 mM oxalic acid solution showed significant depolymerization effect on cotton cellulose. An oxalic acid/sodium oxalate buffered pH gradient had an inhibitory effect on the reduction of cellulose polymers at increased pH values. The organic iron chelator, EDTA, was found to promote depolymerization of cellulose in combination with Fenton’s reagents, but inhibited the effect of oxalic acid in the absence of iron and hydrogen peroxide. Manganese was tested to see if metals other than iron could generate a significant impact on the degree of polymerization (DP) in cotton cellulose. Depolymerizing properties comparable to iron were seen. The results confirm that low molecular weight metabolites are capable of depolymerizing cellulose and suggest an importance of these mechanisms during incipient decay by brown rot fungi. 相似文献
980.
Isaacs RC Newton CL Cutrona KJ Mercer SP Dorsey BD McDonough CM Cook JJ Krueger JA Lewis SD Lucas BJ Lyle EA Lynch JJ Miller-Stein C Michener MT Wallace AA White RB Wong BK 《Bioorganic & medicinal chemistry letters》2011,21(5):1532-1535
Although the S3 pocket of the thrombin active site is lined with lipophilic amino acid residues, the accommodation of polarity within the lipophilic P3 moiety of small molecule inhibitors is possible provided that the polar functionality is capable of pointing away from the binding pocket outwards toward solvent while simultaneously allowing the lipophilic portion of the P3 ligand to interact with the S3 amino acid residues. Manipulation of this motif provided the means to effect optimization of functional potency, in vivo antithrombotic efficacy and oral bioavailability in a series of 3-aminopyrazinone thrombin inhibitors which contained non-charged groups at the P1 position. 相似文献